• Products

    World Bond Fund Monthly Positioning & Outlook

    View Now >

  • Insights

    Human-Centric Investing Podcast

    Listen to Latest Episode >

  • Practice Management

    Applied Insights Team

    Learn More >

  • Resources

    Tax Center

    View Now >

  • About Us

    Human-Centric Investing

    Learn More >

Wen Shi, PhD, CFA

Managing Director and Global Industry Analyst at Wellington Management


 

Background

As a member of the Health Care Team, Wen Shi, PhD, CFA conducts fundamental research on public and private global biotechnology companies.

Prior to joining Wellington Management in 2015, Wen worked as a senior research associate on the global biotechnology team at Sanford C. Bernstein (2013 – 2014). Before Bernstein, he was a consultant to biotech and pharmaceutical companies at Campbell Alliance (2011 – 2013), Navigant Consulting (2009 – 2011), and McKinsey & Company (2007 – 2009).

Wen earned his DPhil (PhD) in medical oncology from Oxford University, where he was a Rhodes Scholar (2007), and BS in biology from Johns Hopkins University (2004). Additionally, he holds the Chartered Financial Analyst designation and is a member of the CFA Institute and the CFA Society Boston.

Experience

Professional experience since 2007

Wellington Management
2015-present

Sanford Bernstein
2013-2014

Campbell Alliance
2011-2013

Navigant Consulting
2009-2011

McKinsey & Company
2007-2009

Education

PhD, Oxford University

BS, Johns Hopkins University

 

224615

The material on this site is for informational and educational purposes only. The material should not be considered tax or legal advice and is not to be relied on as a forecast. The material is also not a recommendation or advice regarding any particular security, strategy or product. Hartford Funds does not represent that any products or strategies discussed are appropriate for any particular investor so investors should seek their own professional advice before investing. Hartford Funds does not serve as a fiduciary. Content is current as of the publication date or date indicated, and may be superseded by subsequent market and economic conditions.

Investing involves risk, including the possible loss of principal. Investors should carefully consider a fund's investment objectives, risks, charges and expenses. This and other important information is contained in the mutual fund, ETF or closed-end interval fund prospectus or summary prospectus, which can be obtained from a financial professional and should be read carefully before investing.

Mutual funds and the closed-end interval fund are distributed by Hartford Funds Distributors, LLC (HFD), Member FINRA/SIPC. Exchange-traded products are distributed by ALPS Distributors, Inc. (ALPS). Advisory services may be provided by Hartford Funds Management Company, LLC (HFMC) or its wholly owned subsidiary, Lattice Strategies LLC (Lattice). Certain funds are sub-advised by Wellington Management Company LLP and/or Schroder Investment Management North America Inc. Schroder Investment Management North America Ltd. serves as a secondary sub-adviser to certain funds. Hartford Funds refers to Hartford Funds Management Group, Inc. and its subsidiaries, including HFD, HFMC, and Lattice, which are not affiliated with any sub-adviser or ALPS. The funds and other products referred to on this Site may be offered and sold only to persons in the United States and its territories.

© Copyright 2021 Hartford Funds Management Group, Inc. All Rights Reserved. Not FDIC Insured | No Bank Guarantee | May Lose Value